Tralokinumab-ldrm is approved for the treatment of moderate-to-severe AD in adult and adolescent patients 12 years and older in the European Union, Canada, Great Britain, the United Arab Emirates, ...
Christina Gentry, DVM, DACVD, discusses how veterinary practitioners can work with these specialists and learn more about dermatology.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果